v3.26.1
Capital Stock (Tables)
9 Months Ended 12 Months Ended
Dec. 31, 2025
Mar. 31, 2025
Capital Stock [Abstract]    
Schedule of Authorized but Unissued Common Stock for Possible Future Issuance  

As of March 31, 2025, the Company has reserved 24,551,226 shares of its authorized but unissued Common Stock for possible future issuance in connection with the following:

 

   Shares 
Long Term Incentive Plan   2,433,728 
Conversion of Preferred Stock   21,688,267 
Exercise of stock warrants   429,231 
Schedule of fair value of Common Stock warrants  

The fair value of the 238,723 Common Stock warrants associated with the Series B equity as of their issuance date was determined to be $394,132 using the Black-Scholes model with the following assumptions.

 

Stock Price  $1.66 
Exercise Price  $.01 
Dividend Yield   0.00%
Volatility   80.00%
Risk-free Rate   3.89 – 4.30%
Expected Years   3.5 
Initial Terms   6 – 7 years 
Schedule of Rollforward of Warrants

The following is a roll forward of warrants for the nine months ended December 31, 2025:

 

   Shares   Price 
Beginning balance   429,230   $1.260 
Issued   760,144    8.395 
Exercised   (303,509)   (0.010)
Expired   (21,440)   (2.332)
Ending balance   864,425   $7.462 

The following is a rollforward of warrants for the years ended March 31, 2025 and 2024:

 

   2025   2024 
   Shares   Price   Shares   Price 
Beginning balance   356,401   $1.570    398,403   $1.810 
Issued   238,723    0.010    
    
 
Exercised   (9,644)   0.010    
    
 
Expired   (156,250)   0.800    (42,002)   2.332 
Ending balance   429,230   $1.260    356,401   $1.570